Alopecia Treatment Update on JAK Inhibitors Ruxolitinib and Tofacitinib

Further to our initial reports on clinical trials involving the study of JAK inhibitor drugs as potential treatments for Alopecia Areata, new information has now become available. Columbia University has just released the findings of this latest study, which have been published in the Science Advances journal. These latest updates bring with them renewed hope for people with Alopecia Areata … Continue reading Alopecia Treatment Update on JAK Inhibitors Ruxolitinib and Tofacitinib